Gene · 1031
Papers2,553
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,553
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Editorial: Advances in brain disorders: from mechanisms to therapeutic targets. | Front Mol Neurosci | 2023 | 38089677 | PubTator, text mining | PubMed |
| Carmofur prevents cell cycle progression by reducing E2F8 transcription in temozolomide-resistant glioblastoma cells. | Cell Death Discov | 2023 | 38086808 | PubTator, text mining | PubMed |
| DRP1: At the Crossroads of Dysregulated Mitochondrial Dynamics and Altered Cell Signaling in Cancer Cells. | ACS Omega | 2023 | 38075775 | PubTator, text mining | PubMed |
| A combination of all-trans retinoic acid derivative and COX-2 inhibitor has anticancer effects in human pharyngeal carcinoma cells. | Heliyon | 2023 | 38074870 | PubTator, text mining | PubMed |
| Chromosomal Instability in Gastric Cancer: Role in Tumor Development, Progression, and Therapy. | Int J Mol Sci | 2023 | 38069284 | PubTator, text mining | PubMed |
| Cytogenetic Profile in Monoclonal Gammopathy of Undetermined Significance, Smoldering and Symptomatic Multiple Myeloma: A Study of 1087 Patients with Highly Purified Plasma Cells. | Cancers (Basel) | 2023 | 38067393 | PubTator, text mining | PubMed |
| Diagnostic Precision in Lyme borreliosis: Assessing VlsE and C6 Antigens in a Pediatric Cohort. | Diagnostics (Basel) | 2023 | 38066788 | PubTator, text mining | PubMed |
| Disulfidptosis-related signatures for prognostic and immunotherapy reactivity evaluation in hepatocellular carcinoma. | Eur J Med Res | 2023 | 38057871 | PubTator, text mining | PubMed |
| Longitudinal drug synergy assessment using convolutional neural network image-decoding of glioblastoma single-spheroid cultures. | Neurooncol Adv | 2023 | 38047207 | PubTator, text mining | PubMed |
| RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma. | Front Immunol | 2023 | 38035078 | PubTator, text mining | PubMed |
| Genomic profiling and immune landscape of olfactory neuroblastoma in China. | Front Oncol | 2023 | 38023213 | PubTator, text mining | PubMed |
| Targeting PEG10 as a novel therapeutic approach to overcome CDK4/6 inhibitor resistance in breast cancer. | J Exp Clin Cancer Res | 2023 | 38017459 | PubTator, text mining | PubMed |
| Dependency of B-Cell Acute Lymphoblastic Leukemia and Multiple Myeloma Cell Lines on MEN1 Extends beyond MEN1-KMT2A Interaction. | Int J Mol Sci | 2023 | 38003662 | PubTator, text mining | PubMed |
| Ellagic Acid and Cancer Hallmarks: Insights from Experimental Evidence. | Biomolecules | 2023 | 38002335 | PubTator, text mining | PubMed |
| Transcriptome Changes in Glioma Cells upon Infection with the Oncolytic Virus VV-GMCSF-Lact. | Cells | 2023 | 37998351 | PubTator, text mining | PubMed |
| PDGF, NGF, and EGF as main contributors to tumorigenesis in high-risk retinoblastoma. | Front Oncol | 2023 | 37965463 | PubTator, text mining | PubMed |
| Langerhans cell histiocytosis: current advances in molecular pathogenesis. | Front Immunol | 2023 | 37965340 | PubTator, text mining | PubMed |
| Combined Inhibition of UBE2C and PLK1 Reduce Cell Proliferation and Arrest Cell Cycle by Affecting ACLY in Pan-Cancer. | Int J Mol Sci | 2023 | 37958642 | PubTator, text mining | PubMed |
| Personalized drug screening in patient-derived organoids of biliary tract cancer and its clinical application. | Cell Rep Med | 2023 | 37944531 | PubTator, text mining | PubMed |
| Olfactory neuroblastoma: diagnosis, management, and current treatment options. | Front Oncol | 2023 | 37909011 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1031/papers?page=5